Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss ...Middle East

Medscape - News
Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss
More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss )

Apple Storegoogle play

Also on site :

Most viewed in News